SCHEMBL6270950

SCHEMBL6270950

CCOC(=O)c1cc2c(C)c(Oc3ccc(O)c(C(=O)c4ccc(F)cc4)c3)c(C)cc2[nH]1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.44
▸ MAPT P10636 5/20 0.44
▸ LMNA P02545 4/20 0.44
▸ THRA P10827 4/20 0.42
▸ THRB P10828 4/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ KDM4E B2RXH2 5/20 0.41
▸ HPGD P15428 5/20 0.41
▸ HSD17B10 Q99714 3/20 0.41
▸ RAB9A P51151 4/20 0.38
▸ NPC1 O15118 3/20 0.38
▸ HTT P42858 2/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ HRH3 Q9Y5N1 1/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ ALOX5 P09917 1/20 0.37
▸ MMP2 P08253 1/20 0.37
▸ MMP13 P45452 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1642280 0.89 THRA (0.49) MAPTTHRATHRBKDM4EHPGD
SCHEMBL6268671 0.86 THRA (0.50) ALDH1A1MAPTLMNATHRATHRB
SCHEMBL6273247 0.82 THRA (0.59) ALDH1A1MAPTLMNATHRATHRB
SCHEMBL6274873 0.82 THRA (0.45) ALDH1A1MAPTLMNATHRATHRB
SCHEMBL6270951 0.79 THRA (0.60) THRATHRB
SCHEMBL6274786 0.79 THRA (0.52) ALDH1A1MAPTLMNATHRATHRB
SCHEMBL6273257 0.78 PDE3B (0.37) ALDH1A1MAPTLMNATHRATHRB
SCHEMBL7082555 0.78 THRA (0.54) THRATHRBALOX5
SCHEMBL7082561 0.75 THRA (0.52) THRATHRB
SCHEMBL1642681 0.75 THRA (0.52) THRATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1297833-B1 Indole carboxylic acids as thyroid receptor ligands PFIZER PROD INC (US) 2005-12-21 — — EP disclosed
US-6723744-B2 FOR THERAPY OF OBESITY, OVERWEIGHT CONDITION, HYPERLIPIDEMIA, GLAUCOMA, CARDIAC ARRHYTHMIAS, SKIN DISORDER, THYROID DISEASE, HYPOTHYROIDISM, THYROID CANCER, DIABETES, ATHEROSCLEROSIS, HYPERTENSION, CORONARY HEART DISEASE, HYPERCHOLESTEREMIA PFIZER, INC. 2004-04-20 — — US disclosed
US-20030078289-A1 Indole carboxylic acids as thyroid receptor ligands ASPNES GARY E (US) 2003-04-24 — — US disclosed
EP-1297833-A1 Indole carboxylic acids as thyroid receptor ligands Pfizer Products Inc. (US) 2003-04-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078289-A1 Indole carboxylic acids as thyroid receptor ligands THRA, MC1R, THRB ALDH1A1 889/4885MAPT 2289/4885LMNA 3208/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback